GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda), are increasingly prescribed for type 2 diabetes and weight management
The breadth of these effects is the point: the receptor does not appear to act through a single disease-specific mechanism but through a general increase in neuronal resilience
"Quality is our guarantee" (brand-stated)
The PatchMD Berberine Patch is specifically formulated to complement these medications with targeted nutrients that help support metabolism, glucose regulation, fat-burning pathways, and overall wellness
Cell Prolif
Behuemn sits in the evidence-based middle: the same molecules the New England Journal trials used delivered with the clinical supervision that makes them safe, effective, and durable